STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 11th, 2019 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), made effective January ___, 2019 (“Effective Date”), is entered into by and between OLAREGEN THERAPEUTIX INC., a Delaware corporation (“Seller” or the “Corporation”) and GENEREX BIOTECHNOLOGY CORPORATION, a Delaware corporation, or an affiliate, (“Purchaser”). Seller and Purchaser are sometimes referred to individually as a “party”, collectively, as “parties.”
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTAdoption Agreement • January 11th, 2019 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS AMENDED and RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of this ____ day of January, 2019 by and among Olaregen Therapeutix Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), which are listed on Schedule A (the “Investors”), Generex Biotechnology Corporation (“Generex”) and the stockholders of the Company listed on Schedule B (the “Key Holders,” and collectively with the Investors and Generex, the “Stockholders”).
PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLYPledge and Security Agreement • January 11th, 2019 • Generex Biotechnology Corp • Pharmaceutical preparations • Delaware
THIS PLEDGE AND SECURITY AGREEMENT (the “Pledge”), is made and entered into this ___ day of January 2019, (“Effective Date”) by and between GENEREX BIOTECHNOLOGY CORPORATION, A Delaware corporation ("Pledgor") and OLAREGEN THERAPEUTIX INC., a Delaware corporation ("Pledgee").
